Table II.
Comparison of MHC Class I Structures in Liganded and Unliganded Forms
| MHC molecule | HLA-A1 | H-2Kb | HLA-A2 | HLA-A2 | HLA-B8 | HLA-B*3508 | H-2Kb | H-2Kb | H-2Kb | H-2Kb | H-2Kbm3 | HLA-Cw4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Peptide | MAGE-A1 | pOV8 | p1049 | Tax | FLR | LPEP | pKB1 | VSV8 | pBM1 | dEV8 | dEV8 | C4CON1 |
| Ligand | Fab-Hyb3 | 25-D1.16 | TCR AHIII12.2 | TCR A6 | TCR LC13 | TCR SB27 | TCR KB5C20 | TCR BM3.3 | TCR BM3.3 | TCR 2C | TCR 2C | KIR2DL1 |
| PDB code, pMHC | 3BO8a | 1VAC33 | 1BOG34 | 1HHK35 | 1M0536 | 1ZHL37 | 1KJ338 | 2VAA39 | 1NAN40 | 1LEG41 | 1LEK41 | 1QQD42 |
| PDB code, pMHC:ligand | 1W7214 | 3CVH43 | 1LP944 | 1AO716 | 1MI545 | 2AK446 | 1KJ238 | 1NAM40 | 1FO047 | 2CKB48 | 1MWA41 | 1IM94 |
| pMHC BSASAb | 990 | 1134 | 1193 | 1021 | 1135 | 1609 | 1482 | 1058 | 704 | 1093 | 1947 | 786 |
| Comparisons of pMHC with pMHC:ligand complexes | ||||||||||||
| HC residues contacting ligand | 9 | 11 | 9 | 7 | 15 | 5 | 6 | 7 | 9 | 5 | 5 | 8 |
| HC residues shifting >2.0 Åc | 4 | 4 | 1 | 3 | 5 | 4 | 2 | 4 | 1 | 1 | 2 | 2 |
| Peptide residues contacting ligand | 3 | 5 | 6 | 5 | 2 | 5 | 3 | 2 | 3 | 3 | 3 | 0 |
| Peptide residues shifting >1.0 Åd | 0 | 3 | 0 | 4 | 1 | 2 | 0 | 1 | 0 | 5 | 5 | 0 |
| Comparisons of rms deviation values (in Å) between pMHC and pMHC:ligand complexes | ||||||||||||
| Peptide | 0.37 | 0.34 | 0.24 | 1.01 | 0.28 | 0.36 | 0.14 | 0.14 | 0.29 | 0.63 | 0.45 | 0.23 |
| HCe | 0.38 | 0.59 | 0.47 | 0.54 | 0.47 | 0.73 | 0.52 | 0.58 | 0.99 | 0.73 | 0.66 | 0.44 |
| β2m | 0.32 | 0.88 | 0.50 | 0.42 | 0.38 | 0.37 | 0.43 | 1.36 | 1.66 | 0.89 | 0.75 | 0.40 |
This study.
Solvent accessible surface area of pMHC buried due to binding of its ligand.
Ligand-contacting HC residues with side chain apex shift ≥2 Å.
Peptide residues with side chain apex shift ≥1 Å.
Only the α1- and α2-domains of the HC are compared.
In those cases where more than one molecule within the asymmetric unit is present, only the first molecule has been analyzed.